Rivaroxaban therapy resulted in the dissolution of left atrial appendage thrombus in 3 patients with nonvalvular atrial fibrillation-related stroke.
Case Report (n=3)
Does rivaroxaban improve dissolution of LAA thrombus in patients with nonvalvular AF-related stroke?
Rivaroxaban may be effective in dissolving left atrial appendage thrombi in patients with nonvalvular atrial fibrillation.
apy 2, 3 . Recently, novel oral anticoagulants (NOACs) have emerged as alternative prophylaxis for thromboembolism in patients with nonvalvular AF. However, the effect of NOACs on intracardiac thrombi has not been fully elucidated. Here we report on the dissolution of LAA thrombus in 3 patients with nonvalvular AFrelated stroke receiving rivaroxaban. The clinical and neuroradiological characteristics of the 3 patients are summarized in table 1 .
Takasugi et al. (Tue,) conducted a case report in Nonvalvular AF-related stroke with LAA thrombus (n=3). Rivaroxaban was evaluated on Dissolution of LAA thrombus. Rivaroxaban therapy resulted in the dissolution of left atrial appendage thrombus in 3 patients with nonvalvular atrial fibrillation-related stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: